Gerresheimer at Pharmapack 2024: Innovative solutions and expert presentations
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Breites Portfolio für Biologika, einschließlich Zell- und Gentherapieprodukte Digital vernetzte Drug Delivery Devices…
BSI Life Sciences today announced biopharma Ocular Therapeutix (NASDAQ: OCUL) as its latest client to go live with its c…
Research collaboration leverages bit.bio’s machine learning-powered discovery platform to identify transcription factor…